Adverse effects of antiglaucoma medications.
Most patients with relatively early glaucomatous damage can be satisfactorily managed with topically or orally administered medications. These drugs, however, can sometimes cause adverse ocular or systemic effects. In this paper the fundamental pharmacologic activity of antiglaucoma medications is reviewed, and appropriate strategies to prevent or manage drug-induced side effects are considered.
J D
JD
Bartlett
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects; D005128:Eye Diseases / Q000139:chemically induced*; D005901:Glaucoma / Q000188:drug therapy*; D005990:Glycerol / Q000009:adverse effects; D006801:Humans; D008353:Mannitol / Q000009:adverse effects; D010277:Parasympathomimetics / Q000009:adverse effects
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D002257:Carbonic Anhydrase Inhibitors; D010277:Parasympathomimetics; D008353:Mannitol; D005990:Glycerol